Bolt Biotherapeutics (BOLT) Earnings Date & Reports
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
BOLT is expected to report earnings to fall 2.38% to -40 cents per share on May 08
Q1'25
Est.
$-0.41
Q4'24
Missed
by $0.06
Q3'24
Missed
by $0.06
Q2'24
Missed
by $0.10
Q1'24
Beat
by $0.23
The last earnings report on March 24 showed earnings per share of -41 cents, missing the estimate of -36 cents. With 167.28K shares outstanding, the current market capitalization sits at 15.34M.